Long-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trials.

Long-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trials.

Item
http://www.wikidata.org/entity/Q35050234
Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy SubjectsBimatoprost 0.03% for the Treatment of Eyelash Hypotrichosis: A Pooled Safety Analysis of Six Randomized, Double-masked Clinical TrialsMulticenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension.An evaluation of the safety and efficacy of bimatoprost for eyelash growth in pediatric subjectsDo Cyclosporine A, an IL-1 Receptor Antagonist, Uridine Triphosphate, Rebamipide, and/or Bimatoprost Regulate Human Meibomian Gland Epithelial Cells?Periorbital muscle atrophy associated with topical bimatoprost therapy.Bimatoprost for eyelash growth in Japanese subjects: two multicenter controlled studies.Patient adherence and persistence with topical ocular hypotensive therapy in real-world practice: a comparison of bimatoprost 0.01% and travoprost Z 0.004% ophthalmic solutions.Corneal epithelial toxicity of antiglaucoma formulations: in vitro study of repeated applicationsInfluence of Pilocarpine and Timolol on Human Meibomian Gland Epithelial Cells.
P2860

Long-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trials.

Item
http://www.wikidata.org/entity/Q35050234
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Long-term safety evaluation of ...... ve-controlled clinical trials.
@ast
Long-term safety evaluation of ...... ve-controlled clinical trials.
@en
type
label
Long-term safety evaluation of ...... ve-controlled clinical trials.
@ast
Long-term safety evaluation of ...... ve-controlled clinical trials.
@en
prefLabel
Long-term safety evaluation of ...... ve-controlled clinical trials.
@ast
Long-term safety evaluation of ...... ve-controlled clinical trials.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P698
P932
P356
P1433
P1476
Long-term safety evaluation of ...... ve-controlled clinical trials.
@en
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P698
P932